Will pimagidine improve survival of diabetics on dialysis?
Friedman
E A
EA
Department of Medicine, State University of New York, Health Science Center at Brooklyn 11203, USA.
D001161:Arteriosclerosis / Q000378:metabolism; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000401:mortality / Q000628:therapy*; D017127:Glycation End Products, Advanced / Q000037:antagonists & inhibitors / Q000378:metabolism; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D006943:Hyperglycemia / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000378:metabolism; D009569:Nitric Oxide / Q000502:physiology; D017582:Renal Replacement Therapy; D016019:Survival Analysis
D017127:Glycation End Products, Advanced; D006146:Guanidines; D009569:Nitric Oxide; C004479:pimagedine